202
Views
1
CrossRef citations to date
0
Altmetric
Research Articles

Preparation and characterization of aqueous vitamin E/Soluplus® dispersions for film coating applications

, , , , & ORCID Icon
Pages 1335-1341 | Received 29 Oct 2020, Accepted 05 Oct 2021, Published online: 15 Oct 2021

References

  • Yang H, Teng F, Wang P, et al. Investigation of a nanosuspension stabilized by Soluplus® to improve bioavailability. Int J Pharm. 2014;477(1–2):88–95.
  • Shamma RN, Basha M. Soluplus®: a novel polymeric solubilizer for optimization of carvedilol solid dispersions: formulation design and effect of method of preparation. Powder Technol. 2013;237:406–414.
  • Hughey JR, Keen JM, Miller DA, et al. The use of inorganic salts to improve the dissolution characteristics of tablets containing Soluplus®-based solid dispersions. Eur J Pharm Sci. 2013;48(4–5):758–766.
  • Salawi A, Nazzal S. The physiochemical, mechanical, and adhesive properties of solvent-cast vitamin E/Soluplus® films. Int J Pharm. 2018;552(1–2):378–387.
  • Salawi A, Nazzal S. The rheological and textural characterization of Soluplus®/vitamin E composites. Int J Pharm. 2018;546(1–2):255–262.
  • Kalantzi L, Reppas C, Dressman JB, et al. Biowaiver monographs for immediate release solid oral dosage forms: acetaminophen (paracetamol). J Pharm Sci. 2006;95(1):4–14.
  • Maniruzzaman M, Boateng JS, Bonnefille M, et al. Taste masking of paracetamol by hot-melt extrusion: an in vitro and in vivo evaluation. Eur J Pharm Biopharm. 2012;80(2):433–442.
  • Kamal MM, Salawi A, Lam M, et al. Development and characterization of curcumin-loaded solid self-emulsifying drug delivery system (SEDDS) by spray drying using Soluplus® as solid carrier. Powder Technol. 2020;369:137–145.
  • Thakhiew W, Devahastin S, Soponronnarit S. Physical and mechanical properties of chitosan films as affected by drying methods and addition of antimicrobial agent. J Food Eng. 2013;119(1):140–149.
  • Borges AF, Silva C, Coelho JFJ, et al. Oral films: current status and future perspectives: I – Galenical development and quality attributes. J Control Release. 2015;206:1–19.
  • Drašković M, Medarević D, Aleksić I, et al. In vitro and in vivo investigation of taste-masking effectiveness of eudragit E PO as drug particle coating agent in orally disintegrating tablets. Drug Dev Ind Pharm. 2017;43(5):723–731.
  • Bodmeier R, Paeratakul O. The effect of curing on drug release and morphological properties of ethylcellulose pseudolatex-coated beads. Drug Dev Ind Pharm. 1994;20(9):1517–1533.
  • Irfan M, Ahmed AR, Kolter K, et al. Curing mechanism of flexible aqueous polymeric coatings. Eur J Pharm Biopharm. 2017;115:186–196.
  • Yang QW, Flament MP, Siepmann F, et al. Curing of aqueous polymeric film coatings: importance of the coating level and type of plasticizer. Eur J Pharm Biopharm. 2010;74(2):362–370.
  • Segur JB, Oberstar HE. Viscosity of glycerol and its aqueous solutions. Ind Eng Chem. 1951;43(9):2117–2120.
  • Felton LA, O’Donnell PB, McGinity JW. Mechanical properties of polymeric films prepared from aqueous dispersions. In: Felton LA, editor. Aqueous polymeric coatings for pharmaceutical dosage forms. Boca Raton: CRC Press; 2016. p. 83–100.
  • Lim H, Hoag SW. Plasticizer effects on physical-mechanical properties of solvent cast Soluplus® films. AAPS PharmSciTech. 2013;14(3):903–910.
  • Blanco-Fernandez B, Rial-Hermida MI, Alvarez-Lorenzo C, et al. Edible chitosan/acetylated monoglyceride films for prolonged release of vitamin E and antioxidant activity. J Appl Polym Sci. 2013;129(2):626–635.
  • El-Malah Y, Nazzal S. Novel use of eudragit NE 30D/eudragit L 30D-55 blends as functional coating materials in time-delayed drug release applications. Int J Pharm. 2008;357(1–2):219–227.
  • Katsuragi Y, Mitsui Y, Umeda T, et al. Basic studies for the practical use of bitterness inhibitors: selective inhibition of bitterness by phospholipids. Pharm Res. 1997;14(6):720–724.
  • Suzuki H, Onishi H, Takahashi Y, et al. Development of oral acetaminophen chewable tablets with inhibited bitter taste. Int J Pharm. 2003;251(1–2):123–132.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.